1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: generic
Raku Co..Ltd

Raku Co..Ltd

TTPEX:4154
12.60
TWD
+0.70
(+5.88%)
-0.92EPS
481.79MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
23.72
31.17
35.78
40.42
33.47
33.8
42.43
32.76
18.36
17.82
11.33
1.57
0.8
0.82
Basic EPS, GAAP
0.82
1.58
-1.63
0.99
-2.85
-2.99
-3.22
-1.68
-3.15
-1.42
-4.41
-4.75
-1.82
-0.89
Free Cash Flow per Basic Share
1.3
0.43
-2.7
-2.22
-2.98
-0.15
1.08
-7.28
-8.41
-4.27
1.95
-1.88
-2.07
-0.87
Dividend per Share
3.19
0.77
1.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
21.96
21.1
16.47
16.5
13.66
15.77
12.44
10.69
13.44
12.86
8.65
7.18
6.36
6.19
Tangible Book Value per Share
21.96
21.1
15.74
15.09
11.91
14.84
12.39
10.48
13.29
12.71
8.56
7.02
6.35
6.17
Basic Weighted Avg Shares
15
14
14
13
13
15
17
17
22
25
25
26
33
36
Sales/Revenue/Turnover
357
450
483
545
451
496
713
550
401
440
279
41
27
30
Operating Margin (%)
2.8
4.73
-2.59
-5.03
-9.99
-10.35
-6.42
-6.35
-25.14
-8.21
-37.54
-231.62
-237.57
-109.87
Depreciation Expense
5
7
7
9
13
17
37
20
28
37
46
37
18
15
Net Income, GAAP
12
23
-22
13
-38
-44
-54
-28
-69
-35
-109
-125
-61
-32
Effective Tax Rate (%)
14.29
11.19
- -
14.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
3.47
5.07
-4.56
2.44
-8.5
-8.84
-7.6
-5.11
-17.19
-7.95
-38.96
-301.66
-226.31
-107.76
Working Capital
283
218
142
162
122
225
216
112
101
5
14
53
71
38
LT Debt
34
12
7
2
2
1
27
23
16
6
3
2
- -
- -
Total Equity
330
294
222
222
184
284
250
258
398
368
243
234
236
251
Return on Invested Capital (%)
2.21
5.57
- -
-9.3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
3.85
7.21
- -
5.91
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
3.53
7.29
-8.54
5.98
-18.87
-19.52
-22.85
-14.49
-26.96
-10.78
-41.03
-57.43
-27.3
-13.76

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7
7
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
38
38
Market Capitalization
555
551
482

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
117
158
101
Cash, Cash Equivalents & STI
73
60
67
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
46
61
62
Payables & Accruals
- -
- -
- -
ST Debt
7
7
1
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.83%
1.98%
0.63%
Free Cash Flow
-206.79%
-60.22%
39.68%
Net Income, GAAP
-28.91%
54.03%
-51.46%
Sales/Revenue/Turnover
-14.8%
-34.89%
-35.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7
15
10
10
41
2025
6
3
7
10
27
2026
5
7
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-1.28
-1.05
-0.91
-1.45
-4.75
2025
-0.74
-0.64
-0.3
-0.2
-1.82
2026
-0.25
-0.15
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Nei Wen Chang
Full Time Employees
47
Sector
Health technology
Industry
Pharmaceuticals: generic
Address
P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road Taipei Taiwan KY1-1205
IPO Date
Jul 27, 2011
Website
raku-tec.com.tw
Similar Companies
Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Jagsonpal Pharmaceuticals Ltd. (NSE:JAGSNPHARM)
Teva Pharmaceutical Industries Limited (TASE:TEVA)
Zim Laboratories Ltd. (NSE:ZIMLAB)
Paradigm Biopharmaceuticals Ltd. (ASX:PAR)
Neuren Pharmaceuticals Limited (ASX:NEU)
Business
Raku Co., Ltd (4154.TWO) engages in the manufacturing, trading and sale of luxury boutique accessories, including metal buttons and fittings for leather products; develops and sells functional drinks and healthcare and beauty products; operates food service, restaurant and entertainment businesses, including art activities and ticket brokerage; and pursues other related operations. The company conducts its activities in Malaysia, Singapore, China, Taiwan, Thailand, Europe and internationally. Incorporated in 2000 and headquartered in Camana Bay, the Cayman Islands, Raku formerly operated as Kino Co., Ltd., changing its name in October 2021 amid a strategic reform that integrated expertise from the KINO team in international strategy and financial planning; it established its first concept factory in Taiwan in 2020, launched a customized factory in Bangkok, Thailand in 2021 with volume production commencing in 2022, and announced a private placement of up to 15 million common shares for funding in early 2025 along with investments in entities such as Raku Holdings Co., Ltd. and True Co., Ltd.